Read more here: Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress
Read more here: Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress
See the rest here: Novo Nordisk A/S: Alhemo® recommended for European approval as first once-daily subcutaneous prophylactic treatment for people living with...
Go here to read the rest: Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition
Read the rest here: Nxera Pharma to Host R&D Day 2024
Go here to see the original: Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement
Read more from the original source: Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer
Excerpt from: Phase III trial results of novel triple combination pill for hypertension published in The Lancet
See original here: ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer
Follow this link: Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024
Read more from the original source: UPDATE -- Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health...
Recent Comments